
|Articles|December 9, 2014
T-Cell Therapy Produced Prolonged Remission in Relapsed Pediatric ALL
Author(s)Stephan Grupp, MD, PhD
In this video from the 2014 ASH Meeting, Dr. Grupp discusses data from a trial using CAR T-cell therapy in children and young adults with relapsed, treatment-resistant ALL.
Advertisement
Stephan Grupp, MD, PhD, of the Children’s Hospital of Philadelphia, discusses the long-term, follow-up data from a trial using CAR T-cell therapy in 39 children and young adults with relapsed, treatment-resistant acute lymphocytic leukemia.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Palbociclib Maintenance Extends PFS in HR+/HER2+ Advanced Breast Cancer
2
Novel 4-Biomarker Panel Improves Early Detection of Pancreatic Cancer
3
Bria-IMT Continues to Improve Survival in Metastatic Breast Cancer
4
New ASCO Guideline Offers Recommendations for Smoldering Multiple Myeloma
5



































